SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-349399
Filing Date
2018-12-14
Accepted
2018-12-14 07:51:34
Documents
4
Period of Report
2018-12-14
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d656228d8k.htm 8-K 20917
2 EX-3.1 d656228dex31.htm EX-3.1 2337
3 EX-3.2 d656228dex32.htm EX-3.2 377138
4 EX-3.3 d656228dex33.htm EX-3.3 206413
  Complete submission text file 0001193125-18-349399.txt   608122
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16174 | Film No.: 181234567
SIC: 2834 Pharmaceutical Preparations